CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Canakinumab Reduces Gout Risk Without Changing SUA Levels

Published: Thu, 20 Sep 2018 08:50:15 EDT
Canakinumab, an interleukin 1bea blocker, was associated with significantly lower risk for gout attacks when given quarterly, but did not change serum uric acid levels, a study has found.
Medscape Medical News

Food Insecurity Linked to High Blood Pressure in Kids

Published: Thu, 20 Sep 2018 08:23:02 EDT
Children who lack good access to nutritional foods are at increased risk of having high blood pressure, prompting a call for providers to screen for food insecurity as a heart disease risk factor.
Medscape Medical News

Big Jump in US Spending on Cancer Drugs From 2011 to 2016

Published: Thu, 20 Sep 2018 06:11:57 EDT
From 2011 to 2016, expenditure on cancer drugs in the United States rapidly accelerated. The first prospective study of its kind tallies the numbers.
Medscape Medical News
Displaying results 13-15 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Novo to lay off 400 staff in major R&D reorganization

Published: Tue, 18 Sep 2018 11:05:22 +0000
Novo Nordisk is laying off 400 employees in China and Denmark as part of a reorganization of its R&D department. The reshuffle comes as the company seeks to build a pipeline of chronic disease drugs capable of mitigating the pressures faced by its core diabetes business.

Roivant launches lung-focused Respivant with phase 2 IPF drug

Published: Mon, 17 Sep 2018 18:46:34 +0000
Roivant Sciences’ spinout machine keeps turning, with the launch of the lung-disease focused Respivant Sciences, a company built around an inhaled drug for treating chronic cough in patients with idiopathic pulmonary fibrosis.

Servier drops GeNeuro’s multiple sclerosis drug after midphase miss

Published: Mon, 17 Sep 2018 15:13:48 +0000
Servier has turned down the chance to license a multiple sclerosis drug from GeNeuro. The decision comes a year after the monoclonal antibody, GNbAC1, failed to beat placebo in a phase 2b trial.
Displaying results 13-15 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top